Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sleepy Med CBT app vs zolpidem for insomnia
jRCT2032230353Active, not recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of zolpidem in Insomnia (2 arms), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Change in subjective sleep onset latency at 5 weeks. Started Dec 2023; status: active, not recruiting.
02
Drugs
zolpidem
03
Conditions
Insomnia
Beyond the preview
Go deeper on jRCT2032230353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2032230353.